advanced search

GI/ORAL

REMOVING CLINICAL TRIAL BIAS WITH OVER-ENCAPSULATION
GI/ORAL
Frédérique Bordes-Picard
Lonza
REMOVING CLINICAL TRIAL BIAS WITH OVER-ENCAPSULATION
Frédérique Bordes-Picard, Julien Lamps and Stephen Rode discuss the considerations to take into account when using over-encapsulation to blind clinical trials, including the advantages of hydroxypropyl methylcellulose over gelatin as a material.
GASTRIC FLOATING MICROCAPSULES FOR THE MANAGEMENT OF PARKINSON’S DISEASE
EARLY INSIGHT
Dr Sashi Kesavapany
GASTRIC FLOATING MICROCAPSULES FOR THE MANAGEMENT OF PARKINSON’S DISEASE
Kaarunya Sampathkumar, Joachim Loo and Sashi Kesavapany discuss current treatments for Parkinson’s disease and introduce an extended-releasing technology for polypharmacy oral formulations.
NANOPARTICLE ENGINEERING AND 3DP DELIVERY FOR GAME-CHANGING ORAL THERAPEUTICS
GI/ORAL
Niklas Sandler
Nanoform
NANOPARTICLE ENGINEERING AND 3DP DELIVERY FOR GAME-CHANGING ORAL THERAPEUTICS
Niklas Sandler and Thomas West consider the technological advances in nanoparticle engineering that can improve the bioavailability and delivery of oral therapeutics.
FORMULATION SOLUTION FOR MOISTURE-SENSITIVE DRUGS
GI/ORAL
Laura Canalejas
Qualicaps
FORMULATION SOLUTION FOR MOISTURE-SENSITIVE DRUGS
Laura Canalejas outlines the benefits of Quali-V® Extra Dry – a hypromellose capsule designed for moisture-sensitive formulations.
SMARTER MEDICINES TO SECURE PRODUCTS AND PROMOTE PATIENT ENGAGEMENT
GI/ORAL
Gary Pond
SMARTER MEDICINES TO SECURE PRODUCTS AND PROMOTE PATIENT ENGAGEMENT
Gary Pond looks at digital authentication and discusses how on-dose microtaggants can provide a high level of security in authenticating tablets and capsules in the fight against counterfeit products.
ADDRESSING ONGOING AND NEW BIOAVAILABILITY CHALLENGES
EXPERT VIEW
Dr Stephanie Emory
ADDRESSING ONGOING AND NEW BIOAVAILABILITY CHALLENGES
Stephanie Emory explores the pros and cons of various technologies for enhancing solubility and bioavailability for oral drug formulations. Further, Dr Emory draws on her experience as a reviewer at the US FDA to discuss how developers can view the FDA as a partner to aid success when leveraging innovative approaches.
PRODUCT SHOWCASE: Evonik’s newly launched EUDRACAP™ functional, ready-to-fill capsules
GI/ORAL
Evonik
PRODUCT SHOWCASE: Evonik’s newly launched EUDRACAP™ functional, ready-to-fill capsules
Evonik introduces EUDRACAP™, its newly launched platform of functional ready-to-fill HPMC capsules, which helps optimise release profile, protects sensitive active ingredients, and speeds time to market.
ANALYTICAL TECHNIQUES FOR THE FORMULATION OF GASTRORETENTIVE TABLETS
EXPERT VIEW
Jamie Clayton
ANALYTICAL TECHNIQUES FOR THE FORMULATION OF GASTRORETENTIVE TABLETS
Jamie Clayton, Phil Bone and Kyu Mok Hwang discuss the value of analyses such as mercury porosimetry and powder rheology in characterising excipients for gastroretentive tablet formulation, and go on to detail a case study investigating polymer excipients for a novel bilayer floating tablet.
LINKING THE “D” & “M” IN CDMO
EXPERT VIEW
Mr John Ross
LINKING THE “D” & “M” IN CDMO
John Ross looks at the role of CDMOs in product development through to commercialisation and considers the benefits of consolidated “DM” models.
INTERVIEW WITH STEVE AMOUSSOU-GUENOU, ROQUETTE
INTERVIEW
Steve Amoussou-Guenou
Roquette
INTERVIEW WITH STEVE AMOUSSOU-GUENOU, ROQUETTE
In this interview, Steve Amoussou-Guenou discusses how Roquette developed the LYCAGEL™ system and how this plant-based alternative compares with traditional gelatin softgel capsules.
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
SUSTAINABILITY
Jiae Kim
Roquette
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.
ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS
INDUSTRIALISATION
Bert Dekens
ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS
Bert Dekens discusses Hosokawa Micron's offering for pharmaceutical powder mixing, including the Cyclomix high-shear mixer and the Nauta low-shear mixer, and how the company’s technology solutions take a broader approach to the full mixing process than simply providing a mixing machine.
SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE
EXPERT VIEW
Rina Chokshi
SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE
Rina Chokshi discusses the benefits of naturally derived, sustainable ingredients and their benefits to the environment and pharmaceutical industry.
LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE
SUSTAINABILITY
Dr Aline Moulin
Skyepharma Production
LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE
Aline Moulin and Laurent Rigaudeau discuss how Skyepharma fulfils its sustainable development policy through its technologies and processes.
NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT
SUSTAINABILITY
Andrea Cusack
leon-nanodrugs
NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT
Andrea Cusack discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
ROUNDTABLE
Dr Jeremy Drummond
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
In this roundtable discussion, Jeremy Drummond, Stephen Rode and Torkel Gren discuss trends with different drug dosage forms for different routes of administration, the rise of patient centricity including the shift from the blockbuster model to more tailored products.
TFF AND UNION AGREE LICENSING PACT FOR TFF TECHNOLOGY WITH NICLOSAMIDE FOR THE TREATMENT OF COVID-19
COVID-19 NEWS
TFF AND UNION AGREE LICENSING PACT FOR TFF TECHNOLOGY WITH NICLOSAMIDE FOR THE TREATMENT OF COVID-19
UNION therapeutics has acquired an option to a worldwide, exclusive licence to TFF Pharmaceuticals' Thin Film Freezing (TFF) technology, in combination with niclosamide, covering oral and inhalation formulations, potentially for covid-19, as well as other niclosamide-based therapies.
MAKING MEDICINE EASIER TO TAKE
GI/ORAL
Graeme Macleod
MAKING MEDICINE EASIER TO TAKE
Graeme Macleod and Wayne Camarco discuss the rational design of excipients to meet the needs of patient-centric formulations.
FORMULATION FLEXIBILITY WITH NEW ERA HPMC CAPSULES
GI/ORAL
Sanjay Powale
ACG
FORMULATION FLEXIBILITY WITH NEW ERA HPMC CAPSULES
Sanjay Powale, Anita Solanki and Dorene Almeida discuss the benefits of HPMC capsules in overcoming challenges faced by traditional gelatin capsules.
THE FLOWABILITY OF LACTOSE POWDERS TO OPTIMISE TABLETING PROCESSES
GI/ORAL
Dr Aurelien Neveu
Granutools
THE FLOWABILITY OF LACTOSE POWDERS TO OPTIMISE TABLETING PROCESSES
Aurélien Neveu, Pauline Janssen and Geoffroy Lumay discuss how new measurement methods can help gain a better understanding of the flowability of lactose powders – a necessary step for future improvement of oral delivery systems.
NANOPARTICLE ENGINEERING: REVOLUTIONISING ORAL DRUG DEVELOPMENT & DELIVERY
GI/ORAL
Dr Satu Lakio
Nanoform
NANOPARTICLE ENGINEERING: REVOLUTIONISING ORAL DRUG DEVELOPMENT & DELIVERY
Satu Lakio and Niklas Sandler discuss the benefits of nanoparticle engineering technology as a means of improving the bioavailability and solubility of drug compounds.
TECHNOLOGY SHOWCASE: Röchling Medical’s Sympfiny<sup>®</sup>
GI/ORAL
Tamas Öri
Röchling Medical
TECHNOLOGY SHOWCASE: Röchling Medical’s Sympfiny®
Röchling Medical presents Sympfiny®, an innovative system for dosing and delivering multiparticulate, dry powder, and microsphere drug formulations for oral delivery, which it developed In collaboration with HS Design.
AN EASY PILL TO SWALLOW
GI/ORAL
Kelly Boyer
AN EASY PILL TO SWALLOW
Kelly Boyer and Ali Rajabi-Siahboomi explore the role of different tablet coating materials in improving the patient experience and adherence to prescription regimens.
INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS
INTERVIEW
Maria Flynn
Adare Pharma Solutions
INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS
Adare Pharma's Maria Flynn talks with ONdrugDelivery about trends in the oral drug development and delivery space, completing the Orbis Biosciences acquisition during a global pandemic, and how the excellent technology portfolio and strategic fit between Orbis and Adare form part of the combined organisation’s unique story.
Top